There is no better tap than Vincerx Pharma Inc (VINC) Stock

H.C. Wainwright raised the price target for the Vincerx Pharma Inc (NASDAQ:VINC) stock to “a Buy”. The rating was released on January 14, 2022, according to finviz. The research report from SVB Leerink has initiated the stock to Outperform, with a price target set at $24. The stock was initiated by Laidlaw, who disclosed in […]